Beauty Health (SKIN) Stock Price, News & Analysis

Company Overview

Beauty Health, Inc. (NASDAQ: SKIN) is a medical aesthetics company best known for its HydraFacial® treatment platform. The company designs, manufactures and commercializes skincare devices and consumables that deliver a multi-step facial therapy combining cleansing, exfoliation, extraction, hydration and antioxidant protection. Beauty Health supports a broad network of physician practices, dermatology clinics, medical spas and wellness centers through direct sales and distribution partnerships.

Beauty Health’s product portfolio centers on the patented Vortex-Fusion® technology underlying HydraFacial, which has been adapted into multiple device models and specialized treatment protocols. In addition to core consumable serums and booster solutions, the company offers turnkey training programs, marketing support and digital tools that help provider partners optimize patient engagement and retention. Beauty Health continues to expand its offerings with advanced treatments targeting scalp health and skin rejuvenation, as well as research and development initiatives focused on next-generation applicators and formulations.

Founded in the late 1990s with the launch of HydraFacial, the company evolved through successive product enhancements and international geographic expansion. Today, Beauty Health is headquartered in Dallas, Texas, and maintains regional offices across North America, Europe, Asia and Latin America. Its executive leadership team brings decades of combined experience in dermatology, medical device development and global business operations, underscoring the company’s commitment to innovation and service excellence.

Looking ahead, Beauty Health aims to drive growth through continued product innovation, expanded global distribution and enhanced digital engagement. The company’s strategy emphasizes sustainable revenue streams through recurring consumable sales, robust training and certification offerings, and strategic alliances with leading aesthetic practitioners worldwide.

Key Stats

• Today's Range: $1.65 to $1.74
• 50-Day Range: $1.46 to $2.42
• 52-Week Range: $0.78 to $2.38
• Volume: 434,429 shs
• Average Volume: 945,619 shs
• Market Capitalization: $209.14 million
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: $1.42
• Consensus Rating: Reduce

Beauty Health Stock Analysis - MarketRank™

Beauty Health scored higher than 6% of companies evaluated by MarketBeat, and ranked 928th out of 943 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: 0.8 / 5
• Analyst Rating: Reduce

Consensus Rating

Beauty Health has received a consensus rating of Reduce. The company's average rating score is 1.67, and is based on no buy ratings, 2 hold ratings, and 1 sell rating.

Amount of Analyst Coverage

Beauty Health has only been the subject of 1 research reports in the past 90 days.

Earnings and Valuation

• Score: 0.0 / 5
• Proj. Earnings Growth: Decreasing

Earnings Growth

Earnings for Beauty Health are expected to decrease in the coming year, from ($0.25) to ($0.30) per share.

Price to Earnings Ratio vs. the Market

The P/E ratio of Beauty Health is -4.05, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

Price to Earnings Ratio vs. Sector

The P/E ratio of Beauty Health is -4.05, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

Price to Book Value per Share Ratio

Beauty Health has a P/B Ratio of 4.05. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.

Short Interest

• Score: 0.0 / 5
• Short Interest Level: Bearish

Percentage of Shares Shorted

15.84% of the float of Beauty Health has been sold short.

Short Interest Ratio / Days to Cover

Beauty Health has a short interest ratio ("days to cover") of 12.4, which indicates bearish sentiment.

Change versus previous month

Short interest in Beauty Health has recently increased by 24.41%, indicating that investor sentiment is decreasing significantly.

Dividend

• Score: 0.0 / 5
• Dividend Strength: N/A

Dividend Yield

Beauty Health does not currently pay a dividend.

Dividend Growth

Beauty Health does not have a long track record of dividend growth.

Sustainability and ESG

• Score: N/A
• Environmental Score: N/A

Percentage of Shares Shorted

15.84% of the float of Beauty Health has been sold short.

Short Interest Ratio / Days to Cover

Beauty Health has a short interest ratio ("days to cover") of 12.4, which indicates bearish sentiment.

Change versus previous month

Short interest in Beauty Health has recently increased by 24.41%, indicating that investor sentiment is decreasing significantly.

News and Social Media

• Score: 2.1 / 5
• News Sentiment: 0.81

News Sentiment

Beauty Health has a news sentiment score of 0.81. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.97 average news sentiment score of Medical companies.

News Coverage This Week

MarketBeat has tracked 23 news articles for Beauty Health this week, compared to 15 articles on an average week.

Company Ownership

• Score: 3.3 / 5
• Insider Trading: N/A

Insider Buying vs. Insider Selling

In the past three months, Beauty Health insiders have not sold or bought any company stock.

Percentage Held by Insiders

41.00% of the stock of Beauty Health is held by insiders. A high percentage of insider ownership can be a sign of company health.

Percentage Held by Institutions

93.26% of the stock of Beauty Health is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

SKIN Stock Analysis - Frequently Asked Questions

How have SKIN shares performed this year?

Beauty Health's stock was trading at $1.59 at the beginning of the year. Since then, SKIN shares have increased by 4.4% and is now trading at $1.66.

How were Beauty Health's earnings last quarter?

The Beauty Health Company (NASDAQ:SKIN) announced its earnings results on Thursday, May, 8th. The company reported ($0.08) earnings per share (EPS) for the quarter, beating analysts' consensus estimates of ($0.13) by $0.05. The business earned $69.60 million during the quarter, compared to the consensus estimate of $63.88 million. Beauty Health had a negative trailing twelve-month return on equity of 67.91% and a negative net margin of 11.94%.
Read the conference call transcript.

Who are Beauty Health's major shareholders?

Top institutional investors of Beauty Health include Kapitalo Investimentos Ltda (0.03%). Insiders that own company stock include Brent L Saunders, Michael P Monahan, Desiree Gruber and Doug K Schillinger.
View institutional ownership trends.

How do I buy shares of Beauty Health?

Shares of SKIN stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

What other stocks do shareholders of Beauty Health own?

Based on aggregate information from My MarketBeat watchlists, some other companies that Beauty Health investors own include Tesla (TSLA), NVIDIA (NVDA), Meta Platforms (META), Advanced Micro Devices (AMD), JPMorgan Chase & Co. (JPM), Netflix (NFLX) and Home Depot (HD).

Company Calendar

• Last Earnings: 5/08/2025
• Today: 7/18/2025
• Next Earnings (Estimated): 8/06/2025
• Fiscal Year End: 12/31/2025

Industry, Sector and Symbol

• Stock Exchange: NASDAQ
• Sector: Medical
• Industry: Medical Services
• Sub-Industry: Medical Equipment
• Current Symbol: NASDAQ:SKIN
• CIK: 1818093
• Web: hydrafacial.com
• Phone: 800-603-4996
• Fax: N/A
• Employees: 1,030
• Year Founded: N/A

Price Target and Rating

• Average Price Target for Beauty Health: $1.42
• High Price Target: $2.00
• Low Price Target: $1.00
• Potential Upside/Downside: -14.7%
• Consensus Rating: Reduce
• Rating Score (0-4): 1.67
• Research Coverage: 3 Analysts

Profitability

• EPS (Trailing Twelve Months): ($0.41)
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: -$29.10 million
• Net Margins: -11.94%
• Pretax Margin: -11.60%
• Return on Equity: -67.91%
• Return on Assets: -5.56%

Debt

• Debt-to-Equity Ratio: 12.01
• Current Ratio: 7.47
• Quick Ratio: 6.43

Sales & Book Value

• Annual Sales: $334.30 million
• Price / Sales: 0.63
• Cash Flow: $0.06 per share
• Price / Cash Flow: 27.20
• Book Value: $0.41 per share
• Price / Book: 4.05

Miscellaneous

• Outstanding Shares: 125,990,000
• Free Float: 74,336,000
• Market Cap: $209.14 million
• Optionable: Optionable
• Beta: 1.22